Nicorette Icy White (Nicotine)

Nicorette Icy White is used in nicotine replacement therapy to support smoking cessation.

• Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms.
• Nicotine dependence: provides controlled nicotine exposure to facilitate gradual reduction.
• Tobacco use disorder: assists individuals who wish to quit tobacco products by substituting nicotine.

• Nicotine in Nicorette Icy White acts as a partial agonist at nicotinic acetylcholine receptors in the central nervous system. By delivering low‑level nicotine stimulation, it alleviates withdrawal symptoms and diminishes the urge to smoke, allowing the user to wean off nicotine dependence gradually.

Nicorette Icy White may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Throat irritation: transient discomfort or scratchy feeling.
• Nausea: occasional upset stomach.
• Headache: mild to moderate intensity.
• Dizziness: brief light‑headed sensation.
• Hiccups: occasional episodes.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or difficulty breathing.
• Chest pain: unexpected discomfort in the chest area.
• Irregular heartbeat: palpitations or arrhythmia.
• Severe mouth ulcer: persistent ulceration requiring medical attention.

When using Nicorette Icy White, consider the following precautions to ensure safe and effective use.

• Cardiovascular assessment: evaluate heart disease before use.
• Use as directed: follow prescribed schedule and do not exceed recommended amount.
• Not for non‑smokers: avoid use in individuals without nicotine dependence.
• Avoid concurrent nicotine products: prevents nicotine overdose.
• Keep out of reach of children: store safely.
• Store at room temperature: keep in original packaging, protect from moisture.

Nicotine can interact with other medicines; be aware of the following potential interactions.

Major Interactions (Avoid)

• Concurrent use of other nicotine replacement therapy: risk of nicotine overdose.
• Use with vasoconstrictive agents (e.g., ergot alkaloids): may increase hypertension risk.
• Combination with beta‑blockers: nicotine‑induced tachycardia may be masked.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., methoxsalen): may raise nicotine plasma levels.
• Monoamine oxidase inhibitors: enhanced nicotine effects and possible mood changes.
• Alcohol consumption: may intensify nicotine cravings and side effects.